[Frequency of methicilin-resistant Staphylococcus aureus strains in clinical spacimens obtained from hospitalized

Mira Mihajlović-Ukropina1, Deana Medić, Zora Jelesić

  • 1Institut za javno zdravlje Vojovodine, Novi Sad Centar za mikrobiologiju.

Medicinski Pregled
|March 4, 2009
PubMed
Abstract

Insights

Methicillin-resistant Staphylococcus aureus (MRSA) was found in 7.5% of hospital isolates. While vancomycin remained effective, high resistance to penicillin and other antibiotics was observed, necessitating ongoing surveillance.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Context:

  • Staphylococcus aureus is a significant cause of hospital and community infections globally.
  • The emergence of methicillin-resistant S. aureus (MRSA) presents a growing public health challenge.
  • Monitoring antibiotic susceptibility patterns is crucial for effective treatment strategies.

Purpose:

  • To determine the frequency of methicillin resistance in S. aureus strains isolated from hospitalized patients.
  • To assess the susceptibility of these strains to commonly used antibiotics, including vancomycin.

Summary:

  • A study of 226 S. aureus strains from hospitalized patients in 2007 found 7.5% resistance to methicillin.
  • All methicillin-resistant strains were susceptible to vancomycin.
  • High resistance rates were observed for penicillin (84.1%) among methicillin-susceptible strains, and varying resistance to other agents, with vancomycin showing universal susceptibility.

Impact:

  • The findings indicate a relatively low rate of MRSA compared to some reports, but highlight the presence of multidrug-resistant strains.
  • The continued susceptibility to vancomycin is a critical finding.
  • Emphasizes the need for continuous monitoring of antibiotic susceptibility to guide infection control and treatment protocols.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...